Stifel Financial
ONCE

Stifel Financial’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Stifel Financial’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,654
Closed -$643K – 3101
2019
Q1 		$643K Buy
+5,654
New +$416K ﹤0.01% 1922
2018
Q3 		– Sell
-2,458
Closed -$204K – 2859
2018
Q2 		$204K Buy
+2,458
New +$190K ﹤0.01% 2540

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Stifel Financial's ONCE Position: Q2 2019 in Review

Stifel Financial sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 5,654 shares — an estimated $643K sold.

Stifel Financial first reported a position in ONCE in Q2 2018 and held it in 2 quarters. The position peaked at $643K in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • Stifel Financial reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Stifel Financial sold 5,654 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $643K.
  • Stifel Financial first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Stifel Financial's Spark Therapeutics, Inc. Common Stock position peaked at $643K in Q1 2019.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Stifel Financial's 13F filing for Q2 2019, filed 14 Aug 2019.